IngenOx Therapeutics

IngenOx Therapeutics Limited is a clinical-stage biopharmaceutical company developing precision oncology drugs and cancer vaccines for difficult-to-treat tumours.

The company serves oncology patients and clinical development partners through a pipeline spanning small molecule immunomodulators, PRMT5 inhibition and peptide-based cancer vaccination.

Its programmes aim to improve immune recognition of tumours and support targeted cancer treatment strategies across colorectal and other cancer indications.